Principal Scientist
Merck & Co., Inc.,, New Jersey
Smeet Deshmukh, Principal Scientist, Pharmaceutical Sciences, Merck & Co., Inc.
Smeet Deshmukh is currently at Merck focused on biologics drug product development. She is been in industry for about 11 years in drug product development for both early and late stage products, oral solids as well as biologics. Her main interests and expertise include scale down models for process development, high concentration formulation development, innovative/alternate approaches to liquid formulation and phase-appropriate risk assessment. Smeet has earned her PhD from Massachusetts Institute of Technology (MIT) in Chemical Engineering and has previously worked at Janssen and BMS.
Disclosure information not submitted.
Monday, October 17, 2022
5:00 PM – 6:00 PM ET